Evidence map›Paper›PMID 28348366›Full record

ArticleScientific reports2017

A novel technique to determine the cell type specific response within an in vitro co-culture model via multi-colour flow cytometry.

Martin J D Clift, Kleanthis Fytianos, Dimitri Vanhecke, Sandra Hočevar, Alke Petri-Fink, Barbara Rothen-Rutishauser

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Martin J D CliftBioNanomaterials, Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland. m.j.d.clift@swansea.ac.uk.
Kleanthis FytianosBioNanomaterials, Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland.
Dimitri VanheckeBioNanomaterials, Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland.
Sandra HočevarBioNanomaterials, Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland.
Alke Petri-FinkBioNanomaterials, Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland.
Barbara Rothen-RutishauserBioNanomaterials, Adolphe Merkle Institute, University of Fribourg, Fribourg, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Determination of the cell type specific response is essential towards understanding the cellular mechanisms associated with disease states as well as assessing cell-based targeting of effective therapeutic agents. Recently, there have been increased calls for advanced in vitro multi-cellular models that provide reliable and valuable tools correlative to in vivo. In this pursuit the ability to assess the cell type specific response is imperative. Herein, we report a novel approach towards resolving each specific cell type of a multi-cellular model representing the human lung epithelial tissue barrier via multi-colour flow cytometry (FACS). We proved via ≤ five-colour FACS that the manipulation of this in vitro model allowed each cell type to be resolved with no impact upon cell viability. Subsequently, four-colour FACS verified the ability to determine the biochemical effect (e.g. oxidative stress) of each specific cell type. This technique will be vital in gaining information upon cellular mechanics when using next-level, multi-cellular in vitro strategies.

Indexed as

Cell SurvivalCoculture TechniquesFlow CytometryHumansLungModels, BiologicalRespiratory MucosaStress, Physiological

Identifiers

PMID28348366
PMCPMC5428288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.